US Bancorp CEO Kedia sells 27,267 shares at $62.37
US BANCORP DE (USB) director and President & CEO Gunjan Kedia reported an option exercise and same‑day sale on August 28, 2026.
Rhea-AI Filing Summary
US BANCORP DE (USB) director and President & CEO Gunjan Kedia reported an option exercise and same‑day sale on August 28, 2026. She exercised 27,267 options at an exercise price of $55.01 per share to acquire an equal number of common shares, then sold 27,267 common shares at a weighted average price of $62.371 per share, with actual sale prices ranging from $62.37 to $62.381. The exercised option award, which vested in four equal annual installments beginning February 16, 2018, now shows 0 options remaining in that grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 27,267 shares ($201K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Kedia Gunjan
Role
President & CEO
Sold
27,267 shs ($1.70M)
Approx. gross sale proceeds
$1.70M
Approx. exercise cost
$1.50M
Approx. pre-tax spread
$201K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) F2 | 27,267 | $0.00 | $0.00 |
| Exercise | Common Stock, $0.01 par value | 27,267 | $55.01 | $1.50M |
| Sale | Common Stock, $0.01 par value F1 | 27,267 | $62.371 | $1.70M |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 0 contracts (Direct);
Common Stock, $0.01 par value — 426,262 shares (Direct)
Footnotes (2)
- F1. The price in Column 4 is a weighted average price. The prices actually received ranged from $62.37 to $62.381. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F2. The options vested in four equal annual installments beginning on February 16, 2018.
Key Figures
Options exercised: 27,267 shares
Option exercise price: $55.01 per share
Common shares acquired on exercise: 27,267 shares
+3 more
6 metrics
Options exercised
27,267 shares
Employee Stock Option (Right to Buy) exercised on August 28, 2026
Option exercise price
$55.01 per share
Conversion or exercise price of Employee Stock Option
Common shares acquired on exercise
27,267 shares
USB common stock received from option exercise on August 28, 2026
Common shares sold
27,267 shares
USB common stock sold on August 28, 2026
Weighted average sale price
$62.371 per share
Sale prices ranged from $62.37 to $62.381 per share
Option expiration date
February 16, 2027
Expiration date of the exercised Employee Stock Option
Key Terms
Employee Stock Option (Right to Buy), Common Stock, $0.01 par value, Exercise or conversion of derivative security, weighted average price
4 terms
Employee Stock Option (Right to Buy) financial
"security_title: "Employee Stock Option (Right to Buy)""
Common Stock, $0.01 par value financial
"underlying_security_title: "Common Stock, $0.01 par value""
Exercise or conversion of derivative security financial
"transaction_code_description: "Exercise or conversion of derivative security""
weighted average price financial
"The price in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
FAQ
What did USB insider Gunjan Kedia report on this Form 4?
Gunjan Kedia, President & CEO and director of USB, reported exercising 27,267 stock options at an exercise price of $55.01 per share and selling 27,267 common shares on August 28, 2026, all as direct ownership transactions.
What options did Gunjan Kedia exercise in this USB Form 4 filing?
She exercised an Employee Stock Option (Right to Buy) for 27,267 shares of USB common stock at an exercise price of $55.01 per share. The option grant was scheduled to expire on February 16, 2027 and vested in four equal annual installments beginning February 16, 2018.
Were the exercised USB options fully used up in this transaction?
Yes. The derivative position row for the Employee Stock Option (Right to Buy) shows 27,267 options exercised and a reported balance of 0 options remaining following the transaction for that specific grant.
Does the filing say these USB trades were under a Rule 10b5-1 plan?
No. The filing’s Rule 10b5‑1 checkbox is not marked as true, and no footnote describes a Rule 10b5‑1 or other pre‑arranged trading plan for these transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
